Disease relevance of Pharmacy and Therapeutics Committee

• As chair of the American Society for Pharmacology and Experimental Therapeutics' Committee on Substance Abuse, Scott Lukas advocates continued research on the effectiveness, toxicity and natural history of anabolic-androgenic steroid abuse [1].

High impact information on Pharmacy and Therapeutics Committee

• Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee [2].
• Furthermore, the CSM should write to the 'Drugs and Therapeutics Committee' of each hospital and encourage them to develop a written local policy for pharmacist ADR reporting [3].
• Growth hormone treatment and risk of solid tumours. A statement from the Drugs and Therapeutics Committee of the European Society for Paediatric Endocrinology (ESPE) [4].
• After the pharmacy and therapeutics committee agreed that filgrastim and sargramostim are therapeutically equivalent, the pharmacy initiated the interchange, with a commitment to collect outcomes data to analyze the impact of the program on patient outcomes [5].
• In 1992 the pharmacy and therapeutics committee at a large teaching hospital accepted cimetidine as the preferred oral H2 antagonist [6].

Associations of Pharmacy and Therapeutics Committee with chemical compounds

• The Pharmacy and Therapeutics Committee at Henry Ford Hospital implemented the formulary replacement of cefoxitin with cefotetan on a cost basis after the agents were evaluated and considered to be therapeutically equivalent [7].
• Hospital guidelines regarding the use of ondansetron were prepared by the Pharmacy and Therapeutics Committee and approved by the Medical Advisory Committee. The guidelines were then distributed to all physicians [8].
• Pharmacy and therapeutics committee review of the parenteral cephalosporins [9].
• In October 1980, the pharmacy and therapeutics committee deleted tobramycin from the formulary because of its high cost and relative lack of therapeutic advantages compared with gentamicin [10].
• Controlling cephalosporin and aminoglycoside costs through pharmacy and therapeutics committee restrictions [11].

Gene context of Pharmacy and Therapeutics Committee

• The Pharmacy and Therapeutics Committee Part 1: overview [12].
• BACKGROUND: This article describes how the Pharmacy and Therapeutics Committee at Lutheran General Hospital (Park Ridge, IL) formed a continuous quality improvement (CQI) team and used statistical process control (SPC) tools to assess efforts to reduce medication errors [13].

References